Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

ACR/ARHP Annual Meeting 2012: Genes Not the Only Factor in Susceptibility to Rheumatoid Arthritis

Susan Bernstein  |  Issue: March 2013  |  March 1, 2013

Smoking and RA Risk

The best example of the interaction between genes and the environment is the connection between cigarette smoking and RA risk, said Dr. Firestein. For example, a person who is a nonsmoker and does not carry the HLA-DR risk gene has a low risk of susceptibility. Nonsmokers who have two copies of the gene have a four- to sixfold increase of susceptibility. People who have two copies of the gene who also smoke have up to a 40-fold increase, he said. Why does this occur? “It’s almost certainly related to environmental exposures and the cellular response to this stress,” Dr. Firestein said.

Citrullination Effects

Citrullination of proteins like vimentin occurs before synovial inflammation begins in RA. Once they are citrullinated, the altered or modified proteins can be mistaken for foreign antigens by the immune system, sparking the inflammatory response. RA-associated MHC proteins bind to many citrullinated proteins more avidly than they do to the native molecules.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Citrullination occurs due to many types of environmental stress, Dr. Firestein said. Very few bacteria are able to citrullinate peptides, but one is the bacterium present in periodontitis, which is associated with an increased risk of RA. Tobacco smoke also can cause peptide modification. “Smoking actually creates these neoepitopes—altered proteins—in the airway,” he said. Citrullinated fibronectin and vimentin activate T cells in patients with the risk-associated HLA-DR genes more effectively than normal peptides, with increased T cytokine production, he added. “This is an appropriate immune response to an altered peptide rather than true autoimmunity.”

Citrullinated proteins have been found in the airways of smokers, further highlighting the connection. Although poor dental hygiene and habitual cigarette smoking can contribute to many different health problems, a person’s genetic makeup plays a role in whether or not they will develop RA, Dr. Firestein added. “People who don’t have the correct genes would be far less likely to see this phenomenon,” he said.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Production of these antibodies precedes synovitis in RA. Most important, one can detect evidence of them five to 10 years before symptoms occur, Dr. Firestein said. Many different types of antibodies are involved, including anticitrullinated protein antibodies (ACPAs) in the majority of patients. Other antibody systems also exist, such as to carbamylated proteins. “If you are ACPA positive and you have arthralgias, you have about a 40% chance of going on to develop RA within two years,” he said.

Page: 1 2 3 4 | Single Page
Share: 

Filed under:ConditionsMeeting ReportsResearch RheumRheumatoid Arthritis Tagged with:ACR/ARHP Annual MeetingepigeneticsResearchRheumatoid arthritis

Related Articles

    ACR Winter Rheumatology Symposium: New Kinase Inhibitors Show Promise

    May 1, 2013

    Toxicity and appropriate targeting are challenges for small molecule researchers

    RA & Huntington’s Disease: New Epigenetic Technology Uncovers Overlap

    November 18, 2018

    Researchers working to decode the epigenetic landscape for rheuma­toid arthritis (RA) were surprised to discover a connection to Huntington’s disease, a finding that could pave the way to discoveries of new therapeutic targets. By developing new methods to integrate data from epigenetic technologies, scientists at the University of California, San Diego (UCSD), set out to…

    The Latest on Epigenetics in Immune-Mediated Disease

    March 19, 2019

    CHICAGO—Because the epigenome has been implicated in a variety of rheumatic conditions, a Basic Research Conference was convened on Epigenetics in Immune-Mediated Disease in conjunction with the 2018 ACR/ARHP Annual Meeting. Melanie Ehrlich, PhD, professor of human genetics and genomics at Tulane University School of Medicine, New Orleans, opened the conference. She has a long…

    Dr. Gary Firestein: Musician & Semi-Retired Surfer

    August 16, 2019

    Roughly 20 years ago, Gary S. Firestein, MD, was surfing at Cloudbreak, a sheltered reef nearly three miles south of Namotu Island in Fiji. With waves soaring as high as 20 feet, it’s either a surfer’s dream or nightmare, and ranked among the 10 most challenging waves anywhere on the planet. At the time, Dr….

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences